--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Preeclampsia Biomarker Test" developer_entity: "Taggart Digital, LLC" bundle_id: "com.RPC.PreeclampsiaBiomarkerTest" app_store_id: "6758343356" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2026-02-01" report_date: "2026-09-09" last_verified: "2026-09-09T00:00:00.000Z" report_version: "1.1" total_reviews: 8 overall_rating: 5 sentiment: "Thrilled" sentiment_score: 90 confidence: "low" confidence_score: 0.3 top_praise_theme: "The clear and simple interface allows users to quickly identify eligibility criteria for clinical testing" review_sample_size: 1 total_review_count: 1 analyzed_review_count: 1 data_age_days: 21 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "free", "thrilled sentiment", "mobile app", "app review", "app analysis", "qualified", "healthcare", "professionals"] canonical_url: "https://marlvel.ai/apps/preeclampsia-biomarker-test" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Preeclampsia Biomarker Test Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free - **Signal**: Rating 5 · Sentiment Thrilled - **Recent focus**: The clear and simple interface allows users to quickly identify eligibility criteria for clinical testing (top praise) > **TL;DR:** Preeclampsia Biomarker Test is a medical app by Taggart Digital, LLC, rated 5/5 by 8 users, with Thrilled user sentiment (90/100), available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Preeclampsia Biomarker Test maintains Thrilled user sentiment (5/5 from 8 reviews), with users consistently praising the clear and simple interface allows users to quickly identify eligibility criteria for clinical testing. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 5/5 (8 reviews) | | **User Mood** | Thrilled | | **Category** | Medical | | **Developer** | Taggart Digital, LLC | | **Pricing** | Free | | **Platforms** | iOS | | **Confidence** | Low (0.3/1.0) | | **Data Age** | 21d | ## Metadata & Market Performance - **Publisher:** Taggart Digital, LLC - **Category:** Medical - **Target Audience:** Qualified healthcare professionals including obstetricians, maternal-fetal medicine specialists, and prenatal care providers. - **Platforms:** iOS - **Version Reviewed:** 1.1 - **Report Date:** 2026-09-09 - **Signal Count:** 1 review analyzed - **Confidence:** Low (0.3/1.0) - **App Store ID (iOS):** 6758343356 - **Bundle ID:** com.RPC.PreeclampsiaBiomarkerTest - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-09-09 ## Executive Snapshot **What it is:** Preeclampsia Biomarker Test is a clinical support utility for obstetricians and prenatal care providers to interpret sFlt-1/PlGF biomarker ratios on iOS. **Why users hire it:** The tool removes the need for manual reference-range lookups during high-pressure clinical assessments, reducing the cognitive load on providers evaluating suspected preeclampsia. ## App DNA (Features & Intent) - **[Standard] Patient Eligibility Assessment:** Calculates testing criteria based on gestational age and clinical presentation. - **[Standard] sFlt-1/PlGF Ratio Interpretation:** Provides actionable guidance for interpreting biomarker test results against clinical reference ranges. * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Local-Only Processing:** Performs all clinical calculations on the device without cloud transmission or data storage. * *User Intent:* Users expect seamless access across multiple devices. ## Market Position {#market-position} Preeclampsia Biomarker Test occupies a niche utility space in the Medical category, maintaining a 5.0 rating across 8 ratings. The lack of recent feature updates relative to its 7-month development gap limits its ability to capture broader clinical workflow market share. ## Monetization Strategy - **Model:** Free - **Tiers:** Free - **Analysis:** Distributed as a free utility with no monetization or subscription tiers. ## 🟢 User Sentiment (Low Confidence: 1 of 1 review analyzed) {#user-sentiment} - **Overall Rating:** 5/5 - **Platform Split:** iOS 5.0/5 (8 ratings) - **Overall Sentiment:** Thrilled ### Top Praises - **The clear and simple interface allows users to quickly identify eligibility criteria for clinical testing** ## SWOT Analysis {#swot} **Core Strengths:** - Local-only processing removes data-privacy barriers for hospital IT compliance **Growth Levers:** - Integration of automated reporting workflows could reduce manual entry time for clinicians ## Recent Changes (v2 → v3) {#recent-changes} The app's competitive posture has shifted from a secure, niche utility to a vulnerable product facing potential medical obsolescence due to a seven-month development gap. The analysis now prioritizes the risk of outdated clinical guidance over the previous focus on international market expansion. **Overall trend**: Mixed **Compared at**: 2026-09-09 ### High-impact changes - **[Shifted] Strategic Outlook Pivot** (positioning) ### Medium-impact changes - **[Added] Updated SWOT Risks and Opportunities** (swot) - **[Removed] Removed International Standards Opportunity** (swot) ## What's New - **Latest (v1.1, 7 months ago):** Added reference data for Biomarker ratio values exceeding 85 and included a clinical use disclaimer. ## App Momentum (Maintenance) {#momentum} - Quiet 7 months, clinical documentation updates only. - Last major release February 2026. > **Cadence:** 1 total versions · 0 majors in last 6 months · 219 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Preeclampsia Biomarker Test is a medical app that is completely free. It holds a 5/5 rating from 8 reviews. > **Bottom Line:** Preeclampsia Biomarker Test provides a stable, privacy-focused reference utility for clinicians, but the lack of active development risks its relevance as clinical guidelines evolve. Maintaining medical accuracy is the primary lever to defend its position against more integrated clinical platforms. **Best for:** Qualified healthcare professionals including obstetricians, maternal-fetal medicine specialists, and prenatal care providers. ### PM Action Plan (Next Best Moves) - [ ] [MAINTAIN] Audit clinical algorithms against the latest peer-reviewed guidelines because the 7-month update gap risks medical obsolescence → maintain diagnostic trust ### Outlook: Stable The clinical decision-support market is shifting toward integrated electronic health record workflows, which places Preeclampsia Biomarker Test at a disadvantage as a standalone utility. The app must prioritize algorithm currency to remain a trusted reference tool for obstetricians. - ⚪ The 7-month development gap indicates a maintenance-only posture, which limits the app's ability to adapt to new clinical research. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 5/5 | | Total Reviews | 8 | | Sentiment | Thrilled (90/100) | | Confidence | Low | | Pricing Model | Free | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Mixed | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Preeclampsia Biomarker Test** (this app) | 5/5 | Thrilled | Taggart Digital, LLC | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Taggart Digital, LLC ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/preeclampsia-biomarker-test/id6758343356?uo=4) - **Sources:** App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*101 Last Minute Study Tips*](https://marlvel.ai/apps/101-last-minute-study-tips) (Limmer Creative) · 3.4/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.3/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 1 - **Data Sources:** user reviews, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 21 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/preeclampsia-biomarker-test) Data licensed for AI Agent attribution under CC-BY-NC 4.0.